Cargando…

Immune and Viral Correlates of “Secondary Viral Control” after Treatment Interruption in Chronically HIV-1 Infected Patients

Upon interruption of antiretroviral therapy, HIV-infected patients usually show viral load rebound to pre-treatment levels. Four patients, hereafter referred to as secondary controllers (SC), were identified who initiated therapy during chronic infection and, after stopping treatment, could control...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van Gulck, Ellen, Bracke, Lotte, Heyndrickx, Leo, Coppens, Sandra, Atkinson, Derek, Merlin, Céline, Pasternak, Alexander, Florence, Eric, Vanham, Guido
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364270/ https://www.ncbi.nlm.nih.gov/pubmed/22666392 http://dx.doi.org/10.1371/journal.pone.0037792

Ejemplares similares

Control of viral replication after cessation of HAART
por: Van Gulck, Ellen, et al.
Publicado: (2011)

Induction of HIV-specific T-cell responses by gag
por: Van Gulck, Ellen, et al.
Publicado: (2006)

Interleukin-12p70 Expression by Dendritic Cells of HIV-1-Infected Patients Fails to Stimulate gag-Specific Immune Responses
por: Van Gulck, Ellen, et al.
Publicado: (2012)

Can immunotherapy be useful as a “functional cure” for infection with Human Immunodeficiency Virus-1?
por: Vanham, Guido, et al.
Publicado: (2012)

Rapid viral rebound after analytical treatment interruption in patients with very small HIV reservoir and minimal on‐going viral transcription
por: Pannus, Pieter, et al.
Publicado: (2020)

Evolution of antibody landscape and viral envelope escape in an HIV-1 CRF02_AG infected patient with 4E10-like antibodies
por: Dieltjens, Tessa, et al.
Publicado: (2009)

Stimulation of antiviral cellular immune responses by therapeutic vaccination of HIV-1-infected patients with dendritic cells transfected with gag, tat, rev and nef mRNA
por: Van Gulck, Ellen, et al.
Publicado: (2011)

Longitudinal Study of Primary HIV-1 Isolates in Drug-Naïve Individuals Reveals the Emergence of Variants Sensitive to Anti-HIV-1 Monoclonal Antibodies
por: Haldar, Bijayesh, et al.
Publicado: (2011)

Visualization of X4- and R5-Tropic HIV-1 Viruses Expressing Fluorescent Proteins in Human Endometrial Cells: Application to Tropism Study
por: Terrasse, Rachel, et al.
Publicado: (2017)

The N276 Glycosylation Site Is Required for HIV-1 Neutralization by the CD4 Binding Site Specific HJ16 Monoclonal Antibody
por: Balla-Jhagjhoorsingh, Sunita S., et al.
Publicado: (2013)

Immunological biomarkers predict HIV-1 viral rebound after treatment interruption
por: Hurst, Jacob, et al.
Publicado: (2015)

HJ16 induced resistant virus displays rare natural mutation highlighting the conserved nature of this new CD4bs epitope
por: Balla-Jhagihoorsingh, Sunita S, et al.
Publicado: (2011)

Characterization of Neutralizing Profiles in HIV-1 Infected Patients from whom the HJ16, HGN194 and HK20 mAbs were Obtained
por: Balla-Jhagjhoorsingh, Sunita S., et al.
Publicado: (2011)

P04-34. Identification of 4E10-like antibodies in plasma of an HIV-1 CRF02_AG infected patient with broad neutralizing activity using peptide phage libraries
por: Dieltjens, T, et al.
Publicado: (2009)

The intraspleen huPBL NOD/SCID model to study the human HIV-specific antibody response selected in the course of natural infection
por: Steyaert, Sophia, et al.
Publicado: (2007)

MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency
por: Grupping, Katrijn, et al.
Publicado: (2012)

An Improved Protocol for Efficient Engraftment in NOD/LTSZ-SCIDIL-2Rγ(NULL) Mice Allows HIV Replication and Development of Anti-HIV Immune Responses
por: Singh, Maneesh, et al.
Publicado: (2012)

P18-08. Characterization of CD34+ derived dendritic cells generated in vitro and transfected with HIV gene as potential therapeutic vaccine in macaque
por: Romain, G, et al.
Publicado: (2009)

Interrupting the Conversation: Implications for Crosstalk Between Viral and Bacterial Infections in the Asthmatic Airway
por: Ackland, Jodie, et al.
Publicado: (2021)

Episomal Viral cDNAs Identify a Reservoir That Fuels Viral Rebound after Treatment Interruption and That Contributes to Treatment Failure
por: Sharkey, Mark, et al.
Publicado: (2011)

Transient viral replication during analytical treatment interruptions in SIV infected macaques can alter the rebound-competent viral reservoir
por: Immonen, Taina T., et al.
Publicado: (2021)

Thyroiditis, Secondary to Viral Infection
por: Marrif, Husnia
Publicado: (2010)

P04-14. Sequential HIV-1 isolates from infected individuals reveals emergence of neutralization sensitive HIV-1 strains in the course of infection
por: Nyambi, PN, et al.
Publicado: (2009)

Cell-associated HIV RNA: a dynamic biomarker of viral persistence
por: Pasternak, Alexander O, et al.
Publicado: (2013)

Molecular Epidemiology of HIV-1 Transmission in a Cohort of HIV-1 Concordant Heterosexual Couples from Dakar, Senegal
por: Jennes, Wim, et al.
Publicado: (2012)

Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in Europe
por: Blanquart, François, et al.
Publicado: (2017)

Predicting Post-treatment HIV Remission: Does Size of the Viral Reservoir Matter?
por: Pasternak, Alexander O., et al.
Publicado: (2021)

Correction: Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in Europe
por: Blanquart, François, et al.
Publicado: (2017)

Monocytes Contribute to Differential Immune Pressure on R5 versus X4 HIV through the Adipocytokine Visfatin/NAMPT
por: Van den Bergh, Rafael, et al.
Publicado: (2012)

P12-11. Resistance to the CD4 mimetic mini protein M48-U1 induces changes in a highly conserved region on the HIV-1 gp120 envelope protein
por: Grupping, K, et al.
Publicado: (2009)

Can immunotherapy be useful for a « functional cure » of HIV infection?
por: Vanham, Guido
Publicado: (2011)

Conserved Secondary Structures in Viral mRNAs
por: Kiening, Michael, et al.
Publicado: (2019)

Secondary Bacterial Infections in Patients With Viral Pneumonia
por: Manohar, Prasanth, et al.
Publicado: (2020)

Residual Proviral Reservoirs: A High Risk for HIV Persistence and Driving Forces for Viral Rebound after Analytical Treatment Interruption
por: Wang, Xiaolei, et al.
Publicado: (2021)

Interferon-stimulated TRIM69 interrupts dengue virus replication by ubiquitinating viral nonstructural protein 3
por: Wang, Kezhen, et al.
Publicado: (2018)

Inhibitory effect of β-escin on Zika virus infection through the interruption of viral binding, replication, and stability
por: Lai, Zheng-Zong, et al.
Publicado: (2023)

Viral Rebound Kinetics Correlate with Distinct HIV Antibody Features
por: Bartsch, Yannic C., et al.
Publicado: (2021)

Increased Proviral DNA in Circulating Cells Correlates with Plasma Viral Rebound in Simian Immunodeficiency Virus-Infected Rhesus Macaques after Antiretroviral Therapy Interruption
por: Ziani, Widade, et al.
Publicado: (2021)

Differences in HIV Markers between Infected Individuals Treated with Different ART Regimens: Implications for the Persistence of Viral Reservoirs
por: Darcis, Gilles, et al.
Publicado: (2020)

Impact of antiretroviral therapy in primary HIV infection on natural killer cell function and the association with viral rebound and HIV DNA following treatment interruption
por: Pace, Matthew, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_br3ivic52b6kabcqgvsskkd2e9